Author: Matucci, A; Caminati, M; Vivarelli, V; Vianello, A; Micheletto, C; Menzella, F; Crisafulli, E; Passalacqua, G; Bagnasco, D; Lombardi, C; Parronchi, P; Crivellaro, M A; Chieco-Bianchi, F; Marchi, M R; Guarnieri, G; Cosmi, L; Rossi, O; Almerigogna, F; Senna, G; Vultaggio, A
Title: COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey. Cord-id: hzgnx8km Document date: 2020_7_27
ID: hzgnx8km
Snippet: Several reports describe an higher risk for viral infections in patients with asthma.1,2 Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.3.
Document: Several reports describe an higher risk for viral infections in patients with asthma.1,2 Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.3.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date